Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 194

    1.

    Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats.

    Muñoz MC, Barberà A, Domínguez J, Fernàndez-Alvarez J, Gomis R, Guinovart JJ.

    Diabetes. 2001 Jan;50(1):131-8.PMID: 11147778 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin-like actions of tungstate in diabetic rats. Normalization of hepatic glucose metabolism.

    Barberà A, Rodríguez-Gil JE, Guinovart JJ.

    J Biol Chem. 1994 Aug 5;269(31):20047-53.PMID: 8051090 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.

    Wasan KM, Risovic V, Yuen VG, McNeill JH.

    J Trace Elem Med Biol. 2006;19(4):251-8. Epub 2005 Dec 13.PMID: 16443173 [PubMed - indexed for MEDLINE]Related articles

    4.

    Defect in glucokinase translocation in Zucker diabetic fatty rats.

    Fujimoto Y, Donahue EP, Shiota M.

    Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E414-23. Epub 2004 May 11.PMID: 15138155 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.

    Upton R, Widdowson PS, Ishii S, Tanaka H, Williams G.

    Br J Pharmacol. 1998 Dec;125(8):1708-14.PMID: 9886762 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Glucokinase overexpression restores glucose utilization and storage in cultured hepatocytes from male Zucker diabetic fatty rats.

    Seoane J, Barberà A, Télémaque-Potts S, Newgard CB, Guinovart JJ.

    J Biol Chem. 1999 Nov 5;274(45):31833-8.PMID: 10542207 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes.

    Cockburn BN, Ostrega DM, Sturis J, Kubstrup C, Polonsky KS, Bell GI.

    Diabetes. 1997 Sep;46(9):1434-9.PMID: 9287043 [PubMed - indexed for MEDLINE]Related articles

    8.

    Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone.

    Cai XJ, Lister CA, Buckingham RE, Pickavance L, Wilding J, Arch JR, Wilson S, Williams G.

    Brain Res Mol Brain Res. 2000 Apr 14;77(1):131-7.PMID: 10814839 [PubMed - indexed for MEDLINE]Related articles

    9.

    Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats.

    Becker DJ, Reul B, Ozcelikay AT, Buchet JP, Henquin JC, Brichard SM.

    Diabetologia. 1996 Jan;39(1):3-11.PMID: 8720597 [PubMed - indexed for MEDLINE]Related articles

    10.

    Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats.

    Torres TP, Catlin RL, Chan R, Fujimoto Y, Sasaki N, Printz RL, Newgard CB, Shiota M.

    Diabetes. 2009 Jan;58(1):78-86. Epub 2008 Oct 24.PMID: 18952838 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Beta cell protective effects of sodium tungstate in streptozotocin-induced diabetic rats: glycemic control, blockage of oxidative stress and beta cell histochemistry.

    Heidari Z, Harati M, Mahmoudzadeh-Sagheb HR, Moudi B.

    Iran Biomed J. 2008 Jul;12(3):143-52.PMID: 18762817 [PubMed - indexed for MEDLINE]Related articles

    12.

    Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.

    Finegood DT, McArthur MD, Kojwang D, Thomas MJ, Topp BG, Leonard T, Buckingham RE.

    Diabetes. 2001 May;50(5):1021-9.PMID: 11334404 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes.

    Fierabracci V, De Tata V, Pocai A, Novelli M, Barberà A, Masiello P.

    Endocrine. 2002 Nov;19(2):177-84.PMID: 12588048 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of tungstate in neonatally streptozotocin-induced diabetic rats: mechanism leading to normalization of glycaemia.

    Barberà A, Fernàndez-Alvarez J, Truc A, Gomis R, Guinovart JJ.

    Diabetologia. 1997 Feb;40(2):143-9.PMID: 9049473 [PubMed - indexed for MEDLINE]Related articles

    15.

    Tungstate is an effective antidiabetic agent in streptozotocin-induced diabetic rats: a long-term study.

    Barberà A, Gomis RR, Prats N, Rodríguez-Gil JE, Domingo M, Gomis R, Guinovart JJ.

    Diabetologia. 2001 Apr;44(4):507-13.PMID: 11357483 [PubMed - indexed for MEDLINE]Related articles

    16.

    Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats.

    Harmon JS, Gleason CE, Tanaka Y, Poitout V, Robertson RP.

    Diabetes. 2001 Nov;50(11):2481-6.PMID: 11679425 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Tissue-specific actions of antidiabetic thiazolidinediones on the reduced fatty acid oxidation in skeletal muscle and liver of Zucker diabetic fatty rats.

    Ide T, Nakazawa T, Mochizuki T, Murakami K.

    Metabolism. 2000 Apr;49(4):521-5.PMID: 10778879 [PubMed - indexed for MEDLINE]Related articles

    18.

    A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats.

    Winter CL, Lange JS, Davis MG, Gerwe GS, Downs TR, Peters KG, Kasibhatla B.

    Exp Biol Med (Maywood). 2005 Mar;230(3):207-16.PMID: 15734724 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Chronic suppression of insulin by diazoxide alters the activities of key enzymes regulating hepatic gluconeogenesis in Zucker rats.

    Alemzadeh R, Holshouser S, Massey P, Koontz J.

    Eur J Endocrinol. 2002 Jun;146(6):871-9.PMID: 12039709 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide.

    Alemzadeh R, Tushaus KM.

    Endocrinology. 2004 Dec;145(12):5476-84. Epub 2004 Aug 19.PMID: 15319354 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data